Akebia Ther (AKBA) earnings · rev $236.2M
These earnings events as JSON? API free 100/dayAkebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
This AKBA earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported AKBA revenue for 2025-12-31 was $236.2M. Net income was -$5.3M. Revenue was up 47.5% from 2024-12-31 to 2025-12-31. AKBA currently screens at market cap $260.1M.
When the next AKBA 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 47.5% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full AKBA research stays on the stock page; the tape stays on the quote page.
AKBA earnings FAQ
What are AKBA's latest revenue and net income?
Latest cached Akebia Ther (AKBA) revenue for Dec 31, 2025 was $236.2M. Net income was -$5.3M. Statements: https://lician.com/financials/akba
What is AKBA's latest diluted EPS?
Latest cached Akebia Ther (AKBA) diluted EPS for Dec 31, 2025 was -$0.02.
What period does the latest AKBA earnings print cover?
The latest cached Akebia Ther (AKBA) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did AKBA revenue change from the prior cached period?
Cached Akebia Ther (AKBA) revenue was up 47.5% from $160.2M (Dec 31, 2024) to $236.2M (Dec 31, 2025). Statements: https://lician.com/financials/akba
Where are AKBA earnings listed?
Cached earnings facts for Akebia Ther (AKBA) are listed at https://lician.com/earnings/akba. Statements: https://lician.com/financials/akba
Not investment advice.